According to the news, Micu Medicine (02335.HK) has started its IPO today, raising more than HK$1 billion. Key cornerstone investors include Qiyuan Hong Kong and Yunding Xinyao (01952.HK).

Zh tng cijng APP xn, mi k yyo -B (02335.HK) y 2026 nin 6 yu 15 - 2026 nin 6 yu 18 r zhog, n qunqi fshu 5805.44 wn g H g, xinggng gngki fshu 580.56 wn g (k chngxn fnpi), guj fshu 5224.88 wn g (k chngxn fnpi), lng yu 15% chobi pig qun. Mi g fshu ji 18.2-21 gngyun, mishu 200 g, yq H g jing y 2026 nin 6 yu 24 r (xngq sn) shngw ji sh zhng kish zi lin jio su mimi. Zhtng Cijng APP news, Macau Pharmaceuticals -B (02335.HK) will be listed from June 15 to June 18, 2026. The company plans to globally sell 58.0544 million H shares, with 5.8056 million shares publicly offered in Hong Kong (which can be redistributed) and 52.2488 million shares offered internationally (which can be redistributed), with an additional 15% over-allotment option. The selling price per share is HK$18.2-21, with a minimum purchase of 200 shares per lot. It is expected that the H shares will begin trading on the Hong Kong Stock Exchange at 9:00 AM on June 24, 2026.